These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27556419)

  • 1. CrossLink: a novel method for cross-condition classification of cancer subtypes.
    Ma C; Sastry KS; Flore M; Gehani S; Al-Bozom I; Feng Y; Serpedin E; Chouchane L; Chen Y; Huang Y
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):549. PubMed ID: 27556419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
    Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
    BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
    Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
    BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiclass prediction with partial least square regression for gene expression data: applications in breast cancer intrinsic taxonomy.
    Huang CC; Tu SH; Huang CS; Lien HH; Lai LC; Chuang EY
    Biomed Res Int; 2013; 2013():248648. PubMed ID: 24490149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.
    Pfefferle AD; Herschkowitz JI; Usary J; Harrell JC; Spike BT; Adams JR; Torres-Arzayus MI; Brown M; Egan SE; Wahl GM; Rosen JM; Perou CM
    Genome Biol; 2013 Nov; 14(11):R125. PubMed ID: 24220145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute assignment of breast cancer intrinsic molecular subtype.
    Paquet ER; Hallett MT
    J Natl Cancer Inst; 2015 Jan; 107(1):357. PubMed ID: 25479802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.
    Wu L; Liu Z; Xu J; Chen M; Fang H; Tong W; Xiao W
    Biomark Med; 2015; 9(11):1053-65. PubMed ID: 26501477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous Domain Adaptation for IHC Classification of Breast Cancer Subtypes.
    Ismailoglu F; Cavill R; Smirnov E; Zhou S; Collins P; Peeters R
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(1):347-353. PubMed ID: 30369448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    Gong IY; Fox NS; Huang V; Boutros PC
    PLoS One; 2018; 13(9):e0204123. PubMed ID: 30216362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unified computational model for revealing and predicting subtle subtypes of cancers.
    Ren X; Wang Y; Wang J; Zhang XS
    BMC Bioinformatics; 2012 May; 13():70. PubMed ID: 22548981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a reliable DNA copy-number-based machine learning algorithm (CopyClust) for breast cancer integrative cluster classification.
    Young CC; Eason K; Manzano Garcia R; Moulange R; Mukherjee S; Chin SF; Caldas C; Rueda OM
    Sci Rep; 2024 May; 14(1):11861. PubMed ID: 38789621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactome-transcriptome integration for predicting distant metastasis in breast cancer.
    Garcia M; Millat-Carus R; Bertucci F; Finetti P; Birnbaum D; Bidaut G
    Bioinformatics; 2012 Mar; 28(5):672-8. PubMed ID: 22238264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtyping for clinically defined breast cancer subgroups.
    Zhao X; Rødland EA; Tibshirani R; Plevritis S
    Breast Cancer Res; 2015 Feb; 17(1):29. PubMed ID: 25849221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simple Method for Robust and Accurate Intrinsic Subtyping of Breast Cancer.
    Hamaneh M; Yu YK
    Cancer Inform; 2023; 22():11769351231159893. PubMed ID: 37008073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model selection for prognostic time-to-event gene signature discovery with applications in early breast cancer data.
    Ahdesmäki M; Lancashire L; Proutski V; Wilson C; Davison TS; Harkin DP; Kennedy RD
    Stat Appl Genet Mol Biol; 2013 Oct; 12(5):619-35. PubMed ID: 24077567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural networks and Fuzzy clustering methods for assessing the efficacy of microarray based intrinsic gene signatures in breast cancer classification and the character and relations of identified subtypes.
    Samarasinghe S; Chaiboonchoe A
    Methods Mol Biol; 2015; 1260():285-317. PubMed ID: 25502389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RRHGE: a novel approach to classify the estrogen receptor based breast cancer subtypes.
    Saini A; Hou J; Zhou W
    ScientificWorldJournal; 2014; 2014():362141. PubMed ID: 24563630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes.
    Ochoa S; de Anda-Jáuregui G; Hernández-Lemus E
    Front Oncol; 2020; 10():845. PubMed ID: 32528899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.